Skip to main content
All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q2 report for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION on July 18, 2026, reporting $50,000 in lobbying income.

Lobbying for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Biopharmaceutical coalition supporting job creation and medical innovation.

All filings by TIBER CREEK GROUP · Everything PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 18, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Issues related to IP protection under Bayh Dole; Issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing; Issues related to S. 2658 - Medication Affordability and Patent Integrity Act.

Medicare/Medicaid

Issues related to IP protection under Bayh Dole; Issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing.

 Bills named in this filing 1
  • S. 2658
    Medication Affordability and Patent Integrity Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem